"Anti-Mullerian Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glycoprotein that causes regression of MULLERIAN DUCTS. It is produced by SERTOLI CELLS of the TESTES. In the absence of this hormone, the Mullerian ducts develop into structures of the female reproductive tract. In males, defects of this hormone result in persistent Mullerian duct, a form of MALE PSEUDOHERMAPHRODITISM.
Descriptor ID |
D054304
|
MeSH Number(s) |
D06.472.334.984.500
|
Concept/Terms |
Anti-Mullerian Hormone- Anti-Mullerian Hormone
- Anti Mullerian Hormone
- Antimullerian Hormone
- Mullerian Inhibiting Hormone
- Mullerian Inhibiting Substance
- Mullerian-Inhibitory Substance
- Mullerian Inhibitory Substance
- Mullerian-Inhibiting Factor
- Mullerian Inhibiting Factor
- Mullerian-Inhibiting Hormone
- Anti-Mullerian Factor
- Anti Mullerian Factor
- Mullerian Regression Factor
|
Below are MeSH descriptors whose meaning is more general than "Anti-Mullerian Hormone".
Below are MeSH descriptors whose meaning is more specific than "Anti-Mullerian Hormone".
This graph shows the total number of publications written about "Anti-Mullerian Hormone" by people in this website by year, and whether "Anti-Mullerian Hormone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2015 | 2 | 0 | 2 |
2016 | 1 | 1 | 2 |
2017 | 5 | 1 | 6 |
2018 | 1 | 2 | 3 |
2019 | 3 | 0 | 3 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Mullerian Hormone" by people in Profiles.
-
Low Anti-Mullerian Hormone Levels Are Associated with the Severity of Anxiety Experienced by Healthcare Professionals During the COVID-19 Pandemic. Reprod Sci. 2022 02; 29(2):627-632.
-
Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve. Hum Reprod. 2020 07 01; 35(7):1630-1636.
-
Insulin Sensitivity Indices in Patients with Polycystic Ovary Syndrome with Different Body Mass Index Categories. Curr Diabetes Rev. 2020; 16(5):483-489.
-
Mullerian inhibiting substance, sex hormone binding globulin and sex hormone levels in stimulant-naïve, first-diagnosed prepubertal boys with attention-deficit/hyperactivity disorder: comparison with matched healthy controls as well as before and after oros-methylpenidate treatment. Int J Psychiatry Clin Pract. 2019 Nov; 23(4):251-257.
-
Anti-Müllerian hormone levels in nurses working night shifts. Arch Environ Occup Health. 2020; 75(3):136-143.
-
AMH and INSL3 in testicular and extragonadal pathophysiology: what do we know? Andrology. 2019 03; 7(2):131-138.
-
Latent genital tuberculosis adversely affects the ovarian reserve in infertile women. Hum Reprod. 2018 07 01; 33(7):1262-1269.
-
In vitro formation of the blood-testis barrier during long-term organotypic culture of human prepubertal tissue: comparison with a large cohort of pre/peripubertal boys. Mol Hum Reprod. 2018 05 01; 24(5):271-282.
-
Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome. Sci Rep. 2018 02 28; 8(1):3795.
-
Anti-Mullerian Hormone-to-Testosterone Ratio is Predictive of Positive Sperm Retrieval in Men with Idiopathic Non-Obstructive Azoospermia. Sci Rep. 2017 12 15; 7(1):17638.